Agricultural Solutions
Q3 2022
Sales in the Agricultural Solutions segment rose considerably compared with the third quarter of 2021. This was mainly attributable to significantly higher prices in all regions and for all indications as well as positive currency effects. Slightly higher volumes, especially in herbicides, also contributed to the positive sales development.
Volumes |
4.6% |
|---|---|
Prices |
16.9% |
Portfolio |
–0.8% |
Currencies |
13.7% |
Sales |
34.5% |
In Europe, sales increased significantly compared with the same quarter of the previous year. Higher prices more than offset negative currency effects, mainly from the Turkish lira, and slightly lower volumes.
Sales in North America rose considerably as a result of positive currency effects, higher prices and increased volumes, especially for herbicides.
The strong sales growth in Asia was primarily driven by significantly higher volumes and positive currency effects, especially in India, China and South Korea. Higher prices also contributed to sales growth.
Sales rose considerably in the region South America, Africa, Middle East due to a successful start to the 2022/23 season. This was primarily the result of higher prices and positive currency effects, especially in Brazil. Higher volumes, especially in herbicides, supported the positive sales development.
Income from operations (EBIT) before special items was considerably above the level of the prior-year quarter due to the positive sales development.
|
Q3 |
January–September |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2022 |
2021 |
+/– |
2022 |
2021 |
+/– |
||||||||||||
Sales to third parties |
2,142 |
1,593 |
34.5% |
7,998 |
6,402 |
24.9% |
||||||||||||
Income from operations before depreciation, amortization and special items |
188 |
74 |
153.8% |
1,625 |
1,284 |
26.6% |
||||||||||||
Income from operations before depreciation and amortization (EBITDA) |
164 |
120 |
36.9% |
1,592 |
1,288 |
23.6% |
||||||||||||
Depreciation and amortizationa |
165 |
164 |
0.6% |
520 |
493 |
5.5% |
||||||||||||
Income from operations (EBIT) |
–1 |
–44 |
98.3% |
1,072 |
795 |
34.8% |
||||||||||||
Special items |
–8 |
46 |
. |
–26 |
3 |
. |
||||||||||||
EBIT before special items |
7 |
–90 |
. |
1,098 |
792 |
38.6% |
||||||||||||
Assets (September 30) |
17,860 |
15,368 |
16.2% |
17,860 |
15,368 |
16.2% |
||||||||||||
Investments including acquisitionsb |
113 |
91 |
23.8% |
245 |
224 |
9.2% |
||||||||||||
Research and development expenses |
225 |
223 |
0.9% |
698 |
667 |
4.7% |
||||||||||||
|
||||||||||||||||||